OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Strategic Leadership in Laboratory Medicine: Navigating Belonging, Resilience, and Organizational Culture	29
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	17
Forthcoming Issues	17
Current Topics in Molecular Diagnostics and Precision Medicine	16
Contributors	15
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	14
Molecular Detection of Oncogenic Gene Rearrangements	12
Molecular Pathology of Ovarian Epithelial Neoplasms	12
Advances in Hemostasis Laboratory Testing	12
Is It Possible to Test for Viral Infectiousness?	11
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	11
Leadership's Role in Paving the Path to Diversity, Equity, and Inclusion in Laboratory Medicine	11
Digital Imaging and AI Pre-classification in Hematology	11
Contributors	11
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	10
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	10
Molecular Oncology Diagnostics	10
Copy Number Analysis in Cancer Diagnostic Testing	10
Contributors	9
Opportunities and Challenges with Artificial Intelligence in Genomics	9
Point-of-Care Drug Testing	9
Contributors	9
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	8
Cell-free Nucleic Acids in Cancer	8
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory	8

Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	7
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	7
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	7
Contents	7
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	6
Contents	6
Flow Cytometry and Platelets	6
Artificial Intelligence for Clinical Flow Cytometry	6
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	6
Expanding the Blood Donor Pool	5
The Evolving Role of Molecular Diagnostics in Pathology	5
Copyright	5
Transfusion Medicine: Renovation, Innovation, and Evolution	5
Electronic Health Record Optimization for Artificial Intelligence	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
The Impact of Inclusive Excellence Initiatives on Laboratory Wellness	5
The Role of Artificial Intelligence in Transfusion Medicine	5
Implementation of Viscoelastic Testing at the Point of Care	5
Updates in Antiphospholipid Syndrome Laboratory Diagnosis	5
Copyright	5
Updates on Von Willebrand Disease Testing	5
Steps Forward to a Fair and Inclusive Blood Supply	5
Molecular Alterations in Pediatric Solid Tumors	5
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	5
Molecular Biomarkers of Response to Cancer Immunotherapy	5
Review of Established and Emerging Infectious Diseases in Transfusion Medicine	4
Copyright	4
Contents	4
Update on Ovarian Sex Cord–Stromal Tumors	4
Point of Care Molecular Testing	4
von Willebrand Disease and von Willebrand Factor	4
Artificial Intelligence in the Clinical Laboratory	4
Copyright	4
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	4
Platelet Laboratory Testing: Integration of Molecular Testing and Advanced Methods	4
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	4
Utility of Single-Gene Testing in Cancer Specimens	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Contributors	4
Contents	4
Diagnostic Stewardship for Multiplex Respiratory Testing	4
Taking Center Stage	4
Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome	4
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3
Bacterial Risk Mitigation Strategies for Platelets	3
Childhood Myelodysplastic Syndrome	3
Analytical Principles of Cancer Next Generation Sequencing	3
Promoting Gender Equality in Pathology and Laboratory Medicine Leadership	3
Molecular Methods	3
An Overview of Common Donor and Therapeutic Apheresis Procedures	3

Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	3
Pathology Clinics Can Address Pathology Burnout	3
Viscoelastic Testing for the Laboratorian	3
Copyright	3
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
Molecular Pathology of Breast Tumors	3
A Winding Road to Health Care Equity in Sickle Cell Disease	3